| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
Key Words. Stem cell • Progenitor • Precursor • Neuronal differentiation • Transdifferentiation • Mitosis • Apoptosis
Ira B. Black, M.D., Department of Neuroscience and Cell Biology, UMDNJ/Robert Wood Johnson Medical School, 675 Hoes Lane, CABM Building, Room 342, Piscataway, New Jersey 08854-5635, USA. Telephone: 732-235-5388; Fax: 732-235-4990; e-mail: black{at}cabm.rutgers.edu
To define relationships among marrow stromal cells (MSCs), multipotential progenitors, committed precursors, and derived neurons, we examined differentiation, mitosis, and apoptosis in vitro. Neural induction medium morphologically converted over 70% of MSCs to typical neurons, which expressed tau, neuronal nuclear antigen, neuron-specific enolase, and TUC-4 within 24 hours. A subset decreased fibronectin expression, consistent with mesenchymal to neuroectodermal conversion. More than 35% of differentiating neurons incorporated bromodeoxyuridine (BrdU) and divided, increasing cell number by 60%, while another subpopulation differentiated without incorporating BrdU or dividing. Inhibition of mitosis and DNA synthesis did not prevent neural differentiation, with 70% of blocked cells expressing tau and displaying neuronal morphologies. By deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay, less than 1% of cells underwent apoptosis at 36 and 72 hours, suggesting differentiation without cell-selective mechanisms. Apparently, MSCs may directly differentiate into neurons without passing through a mitotic stage, suggesting that distinctions among stem cells, progenitors, and precursors are more flexible than formerly recognized.
This article has been cited by other articles:
|
|
 |
|
  S. H. Yoon, Y. S. Shim, Y. H. Park, J. K. Chung, J. H. Nam, M. O. Kim, H. C. Park, S. R. Park, B.-H. Min, E. Y. Kim, et al. Complete Spinal Cord Injury Treatment Using Autologous Bone Marrow Cell Transplantation and Bone Marrow Stimulation with Granulocyte Macrophage-Colony Stimulating Factor: Phase I/II Clinical Trial Stem Cells, August 1, 2007; 25(8): 2066 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kocaoemer, S. Kern, H. Kluter, and K. Bieback Human AB Serum and Thrombin-Activated Platelet-Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue Stem Cells, May 1, 2007; 25(5): 1270 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tropel, N. Platet, J.-C. Platel, D. Noel, M. Albrieux, A.-L. Benabid, and F. Berger Functional Neuronal Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Stem Cells, December 1, 2006; 24(12): 2868 - 2876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bertani, P. Malatesta, G. Volpi, P. Sonego, and R. Perris Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray J. Cell Sci., September 1, 2005; 118(17): 3925 - 3936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Massengale, A. J. Wagers, H. Vogel, and I. L. Weissman Hematopoietic cells maintain hematopoietic fates upon entering the brain J. Exp. Med., May 16, 2005; 201(10): 1579 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. B. BLACK Role of Growth Factors in the Nervous System Ann. N.Y. Acad. Sci., December 1, 2004; 1038(1): 138 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-W. D. Leong, F.-T. Chew, and D. W. Hutmacher Isolating Bone Marrow Stem Cells Using Sieve Technology Stem Cells, November 1, 2004; 22(6): 1123 - 1125. [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Hess, W. D. Hill, J. E. Carroll, and C. V. Borlongan Do Bone Marrow Cells Generate Neurons? Arch Neurol, April 1, 2004; 61(4): 483 - 485. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
